The story of Viagra, and its parent company copyright, presents a challenging case study for investors. Originally a blockbuster drug, generating billions in revenue , its intellectual property lapse created a https://icelisting.com/story22675155/copyright-s-pill-and-pharma-a-risky-opportunity